Results 151 to 160 of about 119,690 (213)

Cardiovascular Disease and Dyslipidemia in Pediatric Type 1 Diabetes. [PDF]

Curr Atheroscler Rep
Kim GK, Brar PC, Bansal N.
europepmc   +1 more source

Impact of Monacolin K-Containing Supplements on Lipid Profile: A Meta-Analysis of Randomised Controlled Trials. [PDF]

Endocrinol Diabetes Metab
Jamialahmadi T, Mirhadi E, Karav S, Kesharwani P, Sahebkar A.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The Inherited Hypercholesterolemias

Endocrinology and Metabolism Clinics of North America, 2022
Inherited hypercholesterolemias include monogenic and polygenic disorders, which can be very rare (eg, cerebrotendinous xanthomatosis (CTX)) or relatively common (eg, familial combined hyperlipidemia [FCH]). In this review, we discuss familial hypercholesterolemia (FH), FH-mimics (eg, polygenic hypercholesterolemia [PH], FCH, sitosterolemia), and other
Wann Jia, Loh, Gerald F, Watts
openaire   +2 more sources

Tendon Pathology in Hypercholesterolemia and Familial Hypercholesterolemia

Current Rheumatology Reports, 2017
Hypercholesterolemia (HC), or high cholesterol, is usually caused by diet, other health conditions, or inherited diseases, such as familial hypercholesterolemia (FHC). Studies have shown patients with hypercholesterolemia are more prone to tendon injury and impaired healing.
Brittany, Taylor, Adnan, Cheema, Louis, Soslowsky   +2 more
openaire   +2 more sources

Vitamin A in Hypercholesterolemia

The American Journal of the Medical Sciences, 1992
This study evaluated the relationship between plasma vitamin A and cholesterol in 48 patients with hypercholesterolemia studied before and after treatment with a cholesterol-lowering diet, with or without lipid-lowering medication. Plasma vitamin A levels were higher in hypercholesterolemic subjects than in healthy controls (2.58 +/- 0.15 vs.
D K, Smith, J M, Greene, S B, Leonard, T T, Kuske, D S, Feldman, E B, Feldman   +5 more
openaire   +2 more sources

Psyllium in Hypercholesterolemia

Annals of Pharmacotherapy, 1995
In summary, within a controlled study situation, psyllium seems to be effective in lowering total and LDL cholesterol by 4-8% and 6-13%, respectively. Compared with conventional antilipidemic agents such as lovastatin, which lowers total cholesterol 30%, LDL cholesterol 40%, and triglycerides 20%, the effect of psyllium on lipids is minimal, and its ...
E K, Chan, D J, Schroeder
openaire   +2 more sources

Screening for Hypercholesterolemia

Annual Review of Medicine, 1990
The detection of individuals with hypercholesterolemia has received world-wide support as a means of determining who would benefit from dietary and pharmacologic interventions. However, the clinician or public health practitioner should be aware of several issues that must be resolved before cholesterol screening can attain maximal impact.
T A, Pearson, S, Bowlin, W R, Sigmund
openaire   +2 more sources